Cargando…
The Place of Sulfonylureas in the Evolving Landscape of Combination Therapy
This article summarizes a presentation from a recent symposium entitled “SUs in the treatment of T2DM: a fresh look and new insights” held on 18 September 2019 during the 55th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Barcelona, Spain, and discusses whether sulfo...
Autor principal: | Yu, Miao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261290/ https://www.ncbi.nlm.nih.gov/pubmed/32323154 http://dx.doi.org/10.1007/s13300-020-00813-1 |
Ejemplares similares
-
The Place of Sulfonylureas in Guidelines: Why Are There Differences?
por: Amod, Aslam
Publicado: (2020) -
The evolving landscape of combination therapy for pulmonary arterial
hypertension
por: Griffin, Matthew, et al.
Publicado: (2016) -
Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
por: Kalra, Sanjay, et al.
Publicado: (2018) -
The evolving place of incretin-based therapies in type 2 diabetes
por: Gallwitz, Baptist
Publicado: (2010) -
Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement
por: Kalra, Sanjay, et al.
Publicado: (2015)